Molding condition: Barrel temperature (from feed and nozzle) C (F):182, 249, 260, 260 (360, 480, 500, 500F) Injection speed: 5.08 mm/min TPE thickness: 1.5 mm.

In this study, Avient’s Trilliant™ HC8900 and Edgetek™ ET8900 thermoplastics were tested alongside competitive materials used for various medical and consumer device enclosures. This study included exposing the materials to leading medical- grade disinfectants, as well as common household disinfectants/cleaners. 4© 2021 Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 MATERIALS AND METHODS The following commercially available healthcare disinfectants were utilized for ESCR testing: CaviCide™, Super Sani-Cloth®, SporGon™, Vesphere® IIse, and Virex® TB.

then a fully- owned subsidiary of Dow Chemical). Prior to joining Dow, she was Corporate Vice President and Global General Manager, Ion Exchange Resins at the Rohm and Haas Company (now a fullyff - owned subsidiary of Dow), where she spent more than 20 years serving in numerous senior roles with increasing responsibilities. Global CARE Insurance (Critical Care Air Rescue and Evacuation), which provides supplemental medical services and medical transportation related to business travel, is also provided to all Named Executive Offiff cers.

COLORANTS & ADDITIVES FOR HEALTHCARE Essential polymer solutions for critical healthcare applications WHEN MATERIAL EXPERTISE IS CRITICAL AESTHETIC APPEAL Regulatory compliant and approved masterbatch colors use custom polymer colorants to achieve any shade SPECIAL EFFECTS Enhance your brand and stand apart with pearlescent, metallic, iridescent, fluorescent or thermo-chromatic effects SOLID TO LIQUID SOLUTIONS Choose from a full range of available color solutions, from liquid color to solid product forms ANTIMICROBIALS Efficacy performance and regulatory requirements are met in a wide range of resins compatible with Withstand™ antimicrobial technology SURFACE ENERGY MODIFICATION Additive technologies such as low retention, hydrophobic, lubricious, light diffusion, or anti-stat provide desired surface manipulation Materials used for today’s medical devices, parts and pharmaceutical packaging contribute significantly to performance and, in turn, to a patient’s health and well-being.

DEFENSE • Battlefield simulation • Flight & vehicle simulation • Medic training • Virtual bootcamp CO NS UMER E DU CA TION • Video games • Live events • Video entertainment • Theatre • Virtual theme parks • Virtual museums & galleries • Virtual immersion • Global connectivity H EALTHCARE • Surgical simulation • Phobia treatment • Robotic surgery • Skills training • Diagnostics R ETAIL & FASHIO N• Virtual stores • 3D human forms for design • 3D fashion portfolios REAL ESTAT E E NG INEERING • 3D modeling tools • Design tools • Prototyping • Construction • Architectural design • Virtual tours 1.844.4AVIENT www.avient.com Copyright © 2020, Avient Corporation.

EPS: $1.00 $0.54 $0.68 $0.30 $0.45 $0.60 $0.75 H1'12 H1'13 Adjusted EPS $101.0 $132.6 $50.0 $100.0 $150.0 H1'12 H1'13 Adjusted Operating Income (millions) +31% $68.6 $97.7 $50.0 $75.0 $100.0 H1'12 H1'13 Specialty Operating Income (millions) First Half 2013 Financial Highlights • Adjusted EPS increased 26% over prior year first half • Operating Income expanded 31% versus first half 2012 • Specialty operating income up 42% • Revenue grew 22% versus 1H ‘12 • Portfolio transformation activities  Completed acquisition of Spartech  Divested non-core Resin business +26% +42% Page 12 • Significant Debt Maturities $ 1,010 Other Debt 21 • Total Debt at 6/30/13 Less: Cash Net Debt • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA = 1.9x • Net Debt / EBITDA = 2.1x*(tax adjusted) $392 310 $702 $1,031 392 $639 $50 $360 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Significant Debt Maturities As of June 30, 2013 ($ millions) Page 13 Coupon Rates: 7.500% 7.375% 5.250% *Pro Forma TTM for taxes on resin gain Debt Maturities & Liquidity Summary – 6/30/13 Cash Balance = $392M Net Debt / EBITDA* = 1.9x • Repurchased ~3.0M shares YTD in 2013 • 17 million shares are available for repurchase under the current authorization Share Repurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Objective of maintaining and growing Dividends • Expanding our sales, marketing, and technical capabilities is top priority • Investing in operational and LSS initiatives (including synergy capture) • CAPEX Organic Growth • Targets that expand our: • Specialty offering • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions • North American manufacturing alignment Acquisitions *TTM 6/30/2013 Use of Cash Page 14 Why Invest In PolyOne?

EPS: $1.00 $0.54 $0.68 $0.30 $0.45 $0.60 $0.75 H1'12 H1'13 Adjusted EPS $101.0 $132.6 $50.0 $100.0 $150.0 H1'12 H1'13 Adjusted Operating Income (millions) +31% $68.8 $97.7 $50.0 $75.0 $100.0 H1'12 H1'13 Specialty Operating Income (millions) First Half 2013 Financial Highlights • Adjusted EPS increased 26% over prior year first half • Operating Income expanded 31% versus first half 2012 • Specialty operating income up 42% • Revenue grew 22% versus 1H ‘12 • Portfolio transformation activities  Completed acquisition of Spartech  Divested non-core Resin business +26% +42% Page 12 • Significant Debt Maturities $ 1,010 Other Debt 21 • Total Debt at 6/30/13 Less: Cash Net Debt • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA = 1.9x* • Net Debt / EBITDA = 2.1x*(tax adjusted) $392 310 $702 $1,031 392 $639 $50 $360 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Significant Debt Maturities As of June 30, 2013 ($ millions) Page 13 Coupon Rates: 7.500% 7.375% 5.250% *Pro Forma TTM Debt Maturities & Liquidity Summary – 6/30/13 Cash Balance = $392M Net Debt / EBITDA* = 1.9x • Repurchased ~3.0M shares YTD in 2013 • 17 million shares are available for repurchase under the current authorization Share Repurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Objective of maintaining and growing Dividends • Expanding our sales, marketing, and technical capabilities is top priority • Investing in operational and LSS initiatives (including synergy capture) • CAPEX Organic Growth • Targets that expand our: • Specialty offering • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions • North American manufacturing alignment Acquisitions *TTM 6/30/2013 Use of Cash Page 14 Why Invest In PolyOne?

EPS: $1.00 First Quarter Financial Highlights • 14th consecutive quarter of double digit adjusted earnings per share growth • 29 percent increase in adjusted EPS  34 percent increase in Specialty operating income  Growth from all regions  Virtually all organic growth • Strengthened our financial position Page 13 • Total Debt at 3/31/13 Less: Cash Net Debt • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA = 2.7x* $169 285 $454 $1,056 169 $887 $50 $360 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2013 ($ millions) Page 14 Coupon Rates: 7.500% 7.375% 5.250% *Pro Forma TTM with no synergies related to Spartech acquisition & excludes resin assets Debt Maturities & Liquidity Summary – 3/31/13 Cash Balance = $169M Net Debt / EBITDA* = 2.7x • Repurchased 840k shares in Q1 2013 • 19.1 million shares are available for repurchase under the current authorization Share Repurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Objective of maintaining and growing Dividends • Expanding our sales, marketing, and technical capabilities is top priority • Investing in operational and LSS initiatives (including synergy capture) • CAPEX Organic Growth • Targets that expand our: • Specialty offering • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions Acquisitions *TTM with no synergies related to the Spartech acquisition Use of Cash Page 15 Why Invest In PolyOne?

EPS: $1.00 First Quarter Financial Highlights • 14th consecutive quarter of double digit adjusted earnings per share growth • 29 percent increase in adjusted EPS  34 percent increase in Specialty operating income  Growth from all regions  Virtually all organic growth • Strengthened our financial position Page 12 • Total Debt at 3/31/13 Less: Cash Net Debt • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA = 2.7x* $169 285 $454 $1,056 169 $887 $50 $360 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2013 ($ millions) Page 13 Coupon Rates: 7.500% 7.375% 5.250% *Pro Forma TTM with no synergies related to Spartech acquisition & excludes resin assets Debt Maturities & Liquidity Summary – 3/31/13 Cash Balance = $169M Net Debt / EBITDA* = 2.7x • Repurchased 840k shares in Q1 2013 • 19.1 million shares are available for repurchase under the current authorization Share Repurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Objective of maintaining and growing Dividends • Expanding our sales, marketing, and technical capabilities is top priority • Investing in operational and LSS initiatives (including synergy capture) • CAPEX Organic Growth • Targets that expand our: • Specialty offering • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions Acquisitions *TTM with no synergies related to the Spartech acquisition Use of Cash Page 14 Why Invest In PolyOne?

The barrel temperature of the injection molding machine was set from 180°C to 235°C (360°F to 455°F) and the injection velocity from 15 mm/sec to 65 mm/sec.